Thus, stabilization of the native 14-3-3/ERα PPI could be useful as an alternative strategy to block ERα transcriptional activity in ERα positive breast cancer, especially in cases of acquired endocrine resistance. This evidence concerns the gene ESR1 and breast cancer.